Pathstone Holdings LLC Reduces Stock Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Pathstone Holdings LLC cut its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 33.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 83,921 shares of the real estate investment trust’s stock after selling 42,549 shares during the quarter. Pathstone Holdings LLC’s holdings in Sabra Health Care REIT were worth $1,562,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Family Firm Inc. acquired a new stake in shares of Sabra Health Care REIT during the second quarter worth $26,000. Assetmark Inc. lifted its position in Sabra Health Care REIT by 168.4% during the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock worth $37,000 after acquiring an additional 1,231 shares during the period. GAMMA Investing LLC grew its stake in Sabra Health Care REIT by 40.0% during the 2nd quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust’s stock valued at $57,000 after purchasing an additional 1,052 shares during the last quarter. Harbor Capital Advisors Inc. acquired a new position in shares of Sabra Health Care REIT in the third quarter valued at about $78,000. Finally, International Assets Investment Management LLC raised its stake in shares of Sabra Health Care REIT by 1,761.0% in the third quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock worth $114,000 after purchasing an additional 5,776 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Health Care REIT Stock Up 0.4 %

SBRA stock opened at $18.91 on Friday. The firm’s fifty day moving average is $18.63 and its 200 day moving average is $16.78. The firm has a market cap of $4.47 billion, a PE ratio of 46.12, a P/E/G ratio of 2.33 and a beta of 1.25. Sabra Health Care REIT, Inc. has a one year low of $12.83 and a one year high of $20.03. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). The business had revenue of $178.00 million during the quarter, compared to analysts’ expectations of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter in the prior year, the firm earned $0.34 EPS. On average, research analysts forecast that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.35%. Sabra Health Care REIT’s dividend payout ratio is currently 292.69%.

Analyst Ratings Changes

A number of equities research analysts recently commented on SBRA shares. Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and upped their target price for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Truist Financial upped their price objective on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Scotiabank raised their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a report on Friday, October 11th. Finally, Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $16.00 to $20.00 in a research report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, Sabra Health Care REIT presently has a consensus rating of “Moderate Buy” and a consensus target price of $18.71.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.